John Conibear

4.7k total citations
28 papers, 313 citations indexed

About

John Conibear is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Conibear has authored 28 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Conibear's work include Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Radiotherapy Techniques (5 papers). John Conibear is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Radiotherapy Techniques (5 papers). John Conibear collaborates with scholars based in United Kingdom, United States and Germany. John Conibear's co-authors include David Landau, Emiliano Spezi, Elizabeth Miles, Matthew Maddocks, Clare Shaw, David Sebag‐Montefiore, Gerard G. Hanna, Srabanti Mukherjee, Gemma Eminowicz and Ken Fearon and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and CHEST Journal.

In The Last Decade

John Conibear

25 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Conibear United Kingdom	10	135	107	77	74	40	28	313
Luc Ollivier France	9	115 0.9×	109 1.0×	45 0.6×	39 0.5×	46 1.1×	33	376
Melissa A.L. Vyfhuis United States	10	201 1.5×	182 1.7×	60 0.8×	89 1.2×	28 0.7×	30	390
Emanuela Olmetto Italy	11	195 1.4×	134 1.3×	92 1.2×	27 0.4×	49 1.2×	38	414
Alice Mège France	7	98 0.7×	72 0.7×	44 0.6×	61 0.8×	31 0.8×	18	281
Rimpa Basu Achari India	10	124 0.9×	62 0.6×	75 1.0×	91 1.2×	11 0.3×	49	286
Ken Le Australia	10	248 1.8×	84 0.8×	171 2.2×	24 0.3×	21 0.5×	24	326
Lagrange Jl France	10	144 1.1×	128 1.2×	68 0.9×	78 1.1×	93 2.3×	32	340
Ceri Powell United Kingdom	11	106 0.8×	119 1.1×	114 1.5×	29 0.4×	16 0.4×	23	349
François Germain Canada	9	66 0.5×	104 1.0×	44 0.6×	41 0.6×	41 1.0×	15	343
Barbara Tolu Italy	9	101 0.7×	60 0.6×	53 0.7×	53 0.7×	19 0.5×	17	271

Countries citing papers authored by John Conibear

Since Specialization

Citations

This map shows the geographic impact of John Conibear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Conibear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Conibear more than expected).

Fields of papers citing papers by John Conibear

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Conibear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Conibear. The network helps show where John Conibear may publish in the future.

Co-authorship network of co-authors of John Conibear

This figure shows the co-authorship network connecting the top 25 collaborators of John Conibear. A scholar is included among the top collaborators of John Conibear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Conibear. John Conibear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dixon, Lauren, et al.. (2025). Sublobar resection or lobectomy for stage Ia non-small cell lung cancer: a systematic review and meta-analysis. BMJ Open Respiratory Research. 12(1). e003234–e003234.

Ricketts, William, et al.. (2024). AI-based approach to enable proactive identification of early lung cancer: A retrospective population health study and economic model.. Journal of Clinical Oncology. 42(16_suppl). 10536–10536. 1 indexed citations

Lee, Alvin, Huan Yan, Yuzhen Jiang, et al.. (2024). A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy. Clinical Oncology. 36(3). 193–199. 2 indexed citations

West, Douglas, John Conibear, Neal Navani, et al.. (2023). The Impact of COVID-19 on Lung Cancer Incidence in England. CHEST Journal. 163(6). 1599–1607. 10 indexed citations

Rogers, Chris, John Conibear, Matthew Evison, et al.. (2023). Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot. BMJ Open. 13(12). e081650–e081650.

Sullivan, Andrew, Krishnaraj S. Rathod, Daniel A. Jones, et al.. (2023). Pericardial Fluid Analysis in Diagnosis and Prognosis of Patients Who Underwent Pericardiocentesis. The American Journal of Cardiology. 198. 79–87. 3 indexed citations

Spira, Alexander I., Joanne Wing Yan Chiu, Alona Zer, et al.. (2023). VELOCITY-Lung: A phase (Ph) 2 study evaluating safety and efficacy of domvanalimab (dom) + zimberelimab (zim) + sacituzumab govitecan (SG), or etrumadenant (etruma) + dom + zim, or etruma + zim in patients (pts) with treatment-naïve metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. 41(16_suppl). TPS9155–TPS9155. 2 indexed citations

Lester, J.F., Carles Escriu, Sarah Khan, et al.. (2021). Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom. BMC Cancer. 21(1). 515–515. 19 indexed citations

Szlosarek, Peter W., Akhila Wimalasingham, Melissa Phillips, et al.. (2021). Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer. Cancer Medicine. 10(19). 6642–6652. 14 indexed citations

10.

Lester, J., Carles Escriu, Sabbir Khan, et al.. (2020). 1379P Real-world (RW) clinical outcomes of patients with metastatic non-small cell lung cancer (mNSCLC) in the United Kingdom. Annals of Oncology. 31. S878–S879. 2 indexed citations

11.

Rosmini, Stefania, Daniel Chen, John Conibear, et al.. (2020). Cardiac computed tomography in cardio-oncology: an update on recent clinical applications. European Heart Journal - Cardiovascular Imaging. 22(4). 397–405. 11 indexed citations

12.

Tsang, Y., Peter Hoskin, Emiliano Spezi, et al.. (2019). Assessment of contour variability in target volumes and organs at risk in lung cancer radiotherapy. Technical Innovations & Patient Support in Radiation Oncology. 10. 8–12. 21 indexed citations

13.

Yang, Haidong, Patricia Díez, Y. Tsang, et al.. (2019). Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials. Clinical Oncology. 32(2). e60–e66. 3 indexed citations

14.

Conibear, John, Yenting Ngai, Andrew Bates, et al.. (2018). Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer. BMJ Open. 8(4). e020690–e020690. 50 indexed citations

15.

Winter, Helen, Sharmin Rahman, John Conibear, et al.. (2018). Virtual metastatic breast multidisciplinary meeting: The next step in personalised medicine.. Journal of Clinical Oncology. 36(15_suppl). e18794–e18794. 1 indexed citations

16.

Landau, David, et al.. (2018). Thoracic intervention and surgery to cure lung cancer: an overview of stereotactic ablative radiotherapy in early and oligometastatic lung cancer. Journal of the Royal Society of Medicine. 112(8). 334–340. 8 indexed citations

17.

Ngai, Yenting, Gerard G. Hanna, John Conibear, et al.. (2017). P3.06-003 SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial. Journal of Thoracic Oncology. 12(1). S1425–S1426. 1 indexed citations

18.

Gooding, Mark J., Kwun-Ye Chu, John Conibear, et al.. (2013). Multicenter Clinical Assessment of DIR Atlas-Based Autocontouring. International Journal of Radiation Oncology*Biology*Physics. 87(2). S714–S715. 8 indexed citations

19.

Gwynne, Sarah, Emiliano Spezi, David Sebag‐Montefiore, et al.. (2013). Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case. British Journal of Radiology. 86(1024). 20120398–20120398. 39 indexed citations

20.

Eminowicz, Gemma, R. Raman, John Conibear, & P.N. Plowman. (2011). Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy. The Journal of Laryngology & Otology. 126(1). 79–82. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact